Letter: should anti-viral therapy be recommended for individuals chronically infected with hepatitis B virus and at low risk of hepatocellular carcinoma? Authors' reply. Alimentary pharmacology & therapeutics Lin, D. n., Yang, H. I., Hoang, J. n., Nguyen, M. H. 2017; 45 (1): 182–83

View details for PubMedID 27910153